How Medmain is Transforming Global Pathology with AI and Cloud Technology
Accelerating Medical DX and Expanding Global Access to Pathology
Plug and Play Japan

Tackling the Global Pathologist Shortage with AI-Powered Digital Solutions
The global healthcare industry faces a critical shortage of pathologists, especially in regions like India, Vietnam, and the GCC countries. Medmain addresses this challenge through PidPort, a next-generation cloud platform that integrates digital slide management, remote collaboration, and advanced AI diagnostics into one seamless system. Already adopted by many medical universities across Japan, PidPort helps clinicians boost efficiency while ensuring diagnostic accuracy.
Medmain’s technology holds particular promise in emerging markets where healthcare infrastructure is underdeveloped, and openness to AI adoption is growing. Their cloud-based platform enables remote diagnoses, rapid AI-powered cancer detection, and collaborative pathology workflows across borders, paving the way for global medical innovation.
Why Is This Problem Significant, & How Large Is Its Impact?
With a corporate mission to "deliver quality medical care wherever and whenever it's needed," Medmain has built a fully integrated digital pathology solution while partnering with medical service providers worldwide. Their services range from digitizing pathology slides to enabling remote diagnostics and AI-powered analysis.
Within the field of pathological diagnosis, they provide a full range of services, from the provision of pathology digitization services, to remote diagnosis support that connects remote facilities via cloud computing, to the provision of highly accurate and rapid pathology AI analysis These cutting-edge technologies are now being implemented in hospitals and research centers to improve outcomes and reduce workloads in pathology departments worldwide.
Additionally, their proprietary AI engine, developed through innovative transfer learning techniques, can detect cancer across multiple organs with high accuracy and speed.
Meet the Team Behind Medmain
Medmain is led by Osamu Iizuka, a visionary CEO who is strongly committed to solving healthcare bottlenecks through advanced technology. Under his leadership, the company has built strong foundations in Japan and is actively expanding its presence in international markets, supported by offices in Tokyo, Fukuoka, and Silicon Valley.
Why We’re Excited to Invest
At Plug and Play, we believe Medmain’s AI-powered pathology platform is redefining the future of diagnostic medicine. As medical DX gains momentum globally, we are proud to support Medmain’s vision of democratizing access to advanced diagnostics through scalable, cloud-based solutions. Our investment will also unlock new synergies by connecting Medmain to our global healthcare network and open innovation ecosystem.
We look forward to accelerating Medmain’s international expansion and supporting their mission to transform pathology across the globe.
Plug and Play is one of the most active VCs in Silicon Valley. Our goal is to fund the teams building the defensible businesses of the future. Join our ecosystem today.





